Minireviews
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6349-6359
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6349
Figure 1
Figure 1 Prevalence of primary Helicobacterpylori resistance to antibiotics in China, Japan, and South Korea. CAM: Clarithromycin; MDZ: Metronidazole; LVFX: Levofloxacin; AMX: Amoxicillin; TET: Tetracycline.